valsartan has been researched along with Cognition Disorders in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Celli, D; Colombo, R; Galo, J | 1 |
| Hirsh Raccah, B; Matok, I; Muszkat, M; Perlman, A | 1 |
| Feng, GF; Han, H; Hu, XD; Liu, Y; Qian, YH; Shi, LL; Yang, WN | 1 |
1 review(s) available for valsartan and Cognition Disorders
| Article | Year |
|---|---|
Effect of Sacubitril/Valsartan on Neurocognitive Function: Current Status and Future Directions.
Topics: Aminobutyrates; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Clinical Trials as Topic; Cognition Disorders; Drug Combinations; Heart Failure; Humans; Neprilysin; United States; United States Food and Drug Administration; Valsartan | 2021 |
2 other study(ies) available for valsartan and Cognition Disorders
| Article | Year |
|---|---|
Cognition- and Dementia-Related Adverse Effects With Sacubitril-Valsartan: Analysis of the FDA Adverse Event Report System Database.
Topics: Aged; Aminobutyrates; Angiotensin Receptor Antagonists; Biphenyl Compounds; Cognition; Cognition Disorders; Dementia; Drug Combinations; Female; Heart Failure; Humans; Incidence; Male; Neprilysin; Retrospective Studies; Stroke Volume; Tetrazoles; United States; United States Food and Drug Administration; Valsartan | 2018 |
The effects of valsartan on cognitive deficits induced by aluminum trichloride and d-galactose in mice.
Topics: Acetylcholinesterase; Aluminum Chloride; Aluminum Compounds; Animals; Cerebral Cortex; Chlorides; Cognition Disorders; Dementia; Disease Models, Animal; Galactose; Glutathione Peroxidase; Hippocampus; Malondialdehyde; Maze Learning; Memory Disorders; Mice; Nootropic Agents; Oxidative Stress; Random Allocation; Superoxide Dismutase; Tetrazoles; Valine; Valsartan | 2014 |